The highest aspirations in the fight against cancer are of little worth unless we have the ability to deliver, and deliver well. This is crucial if the Haematology Oncology Research Group (HORG) is to succeed and become one of Asia’s leading cancer research groups.
One of the biggest challenges I have found is that you can have all the best aspirations to bring fantastic treatment to patients, but everything becomes secondary if you cannot execute these expectations.
It allows us the proper framework to do the work that needs to be done. You need proper infrastructure because clinical research involves everything from negotiations with companies, ensuring that data is collected and entered at the highest levels of accuracy, and following all the international regulations and guidelines for safety, efficacy, and ethics.
Professor John Wong
Director of the National University Cancer
Institute, Singapore (NCIS)